Følling I - Search Results

1

Metformin increases circulating tumour necrosis factor-alpha levels in non-obese non-diabetic patients with coronary heart disease.

Carlsen SM, Waage A, Grill V, Følling I. Carlsen SM, et al. Among authors: folling i. Cytokine. 1998 Jan;10(1):66-9. doi: 10.1006/cyto.1997.0253. Cytokine. 1998. PMID: 9505147

2

Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.

Carlsen SM, Rossvoll O, Bjerve KS, Følling I. Carlsen SM, et al. Among authors: folling i. J Intern Med. 1996 Mar;239(3):227-33. doi: 10.1046/j.1365-2796.1996.444790000.x. J Intern Med. 1996. PMID: 8772621 Clinical Trial.

3

Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease.

Carlsen SM, Følling I, Grill V, Bjerve KS, Schneede J, Refsum H. Carlsen SM, et al. Among authors: folling i. Scand J Clin Lab Invest. 1997 Oct;57(6):521-7. doi: 10.3109/00365519709084603. Scand J Clin Lab Invest. 1997. PMID: 9350072 Clinical Trial.

4

Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease.

Carlsen SM, Grill V, Følling I. Carlsen SM, et al. Among authors: folling i. Diabetes Res Clin Pract. 1998 Jan;39(1):47-54. doi: 10.1016/s0168-8227(97)00121-6. Diabetes Res Clin Pract. 1998. PMID: 9597374 Clinical Trial.

5

[Metformin reevaluated--time for rehabilitation?].

Carlsen SM, Følling I. Carlsen SM, et al. Among authors: folling i. Tidsskr Nor Laegeforen. 1994 Apr 10;114(9):1074-6. Tidsskr Nor Laegeforen. 1994. PMID: 8009522 Review. Norwegian.

6

[New diagnostic criteria for diabetes mellitus--why?].

Grill V, Claudi T, Følling I, Jenssen T, Hanssen K, Jervell J. Grill V, et al. Among authors: folling i. Tidsskr Nor Laegeforen. 2000 Jun 20;120(16):1876-7. Tidsskr Nor Laegeforen. 2000. PMID: 10925616 Free article. Norwegian.

7

Pharmacokinetics of transperitoneal insulin transport.

Widerøe TE, Dahl KJ, Smeby LC, Balstad T, Cruischank-Flakne S, Følling I, Simondsen O, Ahlmen J, Jørstad S. Widerøe TE, et al. Among authors: folling i. Nephron. 1996;74(2):283-90. doi: 10.1159/000189322. Nephron. 1996. PMID: 8893142

8

A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.

Raeder H, Bjørkhaug L, Johansson S, Mangseth K, Sagen JV, Hunting A, Følling I, Johansen O, Bjørgaas M, Paus PN, Søvik O, Molven A, Njølstad PR. Raeder H, et al. Among authors: folling i. Diabetes. 2006 Jun;55(6):1899-903. doi: 10.2337/db05-1677. Diabetes. 2006. PMID: 16731861

9

The clinical value of glycated haemoglobin and glycated plasma proteins.

Følling I. Følling I. Scand J Clin Lab Invest Suppl. 1990;202:95-8. Scand J Clin Lab Invest Suppl. 1990. PMID: 2075462 No abstract available.

10

[Can diabetes be cured by islet transplantation?].

Følling I. Følling I. Tidsskr Nor Laegeforen. 1993 Sep 30;113(23):2889-90. Tidsskr Nor Laegeforen. 1993. PMID: 8236186 Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters